Back to discover
Disease

Testicular Diseases

Clinical development underwayEmerging research
1
Publications
1
Clinical trials
12
Associated genes
3
Related proteins
2001
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Clinical trials

1 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
1
All trials
0
Active
0
Late-stage
1
Completed
Recently completed
Phase 2 · Completed · National Cancer Institute, Slovakia

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Most influential
Recent publications
Major themes1
  • Environmental Exposure1
Leading journals1
  • Human reproduction (Oxford, England)1
Leading researchers3
  • Main KM1
  • Rajpert-De Meyts E1
  • Skakkebaek NE1
Affiliations (unnormalised)1
  • Copenhagen University Hospital1

Associated genes

12 matches

Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.

Disease biology

3 matches

Proteins whose encoding gene is associated with this disease, reached through the canonical gene→disease graph. Number shows the gene's association score.

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Pathological processes of the TESTIS.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.